GMP certification of HYD’s facility

Budapest Business Journal reported, that Hungarian cancer research and drug developer HYD was awarded good manufacturing practice (GMP) certification and, simultaneously, registered deuterium-depleted water as an active ingredient with the European Medicines Agency, according to the Hungarian news agency MTI.

The article can be viewed here.

2015. july 30. thursday